Clinical trials: Consumption, Tobacco
Hospitalized Smokers, Chronic Diseases
Enhancing Tobacco Abstinence Following Hospitalization
The primary aim of this study is to examine the efficacy of a 12-week nurse-delivered relapse management intervention designed with conceptual underpinnings from Self-efficacy Theory to enhance smoking abstinence of hospitalized…
- Conditions
- Hospitalized Smokers, Chronic Diseases, Tobacco Use Disorder
- Trial name
- NCT00222703
- Testing
- Smoking relapse prevention
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- University of Pittsburgh
Tobacco Use Disorder
Smartphone-based Financial Incentives
Cigarette smoking during pregnancy increases risk for catastrophic pregnancy complications, growth retardation, other adverse fetal and infant health problems, and later-in-life chronic conditions among exposed offspring.
- Trial name
- NCT03922360
- Testing
- Smartphone-based Financial Incentives, Best Practices
- Where
- United States
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- University of Vermont
Pulmonary TB
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung…
- Trial name
- NCT05426720
- Testing
- no intervention
- Where
- 2 sites in China
- Volunteers
- 400 people
- Sponsor
- Peking University Third Hospital
Bladder Cancer, Cervical Cancer
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit…
- Conditions
- Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer
- Trial name
- NCT00790569
- Testing
- nicotine, varenicline
- Where
- United States
- Volunteers
- 315 people
- Sponsor
- Butler Hospital
Tobacco Use Cessation
Usefulness of Selegiline as an Aid to Quit Smoking - 1
Despite the widespread use of nicotine replacement therapies for the treatment of nicotine dependence, many smokers are still unable to quit smoking.
- Trial name
- NCT00129311
- Testing
- Selegiline
- Where
- United States
- Volunteers
- 101 people, healthy volunteers welcome
- Sponsor
- Yale University
Tobacco Use Cessation, Cancer
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.
- Trial name
- NCT05805722
- Testing
- Behavioral counseling for tobacco cessation
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- Virginia Commonwealth University
Tobacco Use Cessation
IMPACT OF PAMPHLET ON THE KNOWLEDGE OF HEALTH EFFECT OF SMOKING
Tobacco smoke is one of the most preventable cause of mortality and morbidity worlwide, this study is conducted to compare the knowledge of the health effects of smoking among undergraduates exposed and those not exposed to…
- Trial name
- NCT03316495
- Testing
- PAMPHLET
- Where
- Nigeria
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- University of Benin
Tobacco Dependence
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income…
- Trial name
- NCT06289192
- Testing
- C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker
- Where
- 3 sites in United States
- Volunteers
- 5 people
- Sponsor
- Johns Hopkins University
Severe Mental Illness, Nicotine Dependence
Electronic Decision Support Systems for Smokers With Severe Mental Illness
This randomized clinical trial among SMI smokers assessed whether the EDSS with carbon monoxide monitor and health-checklist feedback lead to higher rates of initiation of smoking cessation treatment, days of smoking abstinence…
- Conditions
- Severe Mental Illness, Nicotine Dependence, Schizophrenia, Tobacco Use Disorder
- Trial name
- NCT01412866
- Testing
- EDSS with CO feedback and health checklist, EDSS with health checklist feedback alon
- Where
- United States
- Volunteers
- 124 people
- Sponsor
- Dartmouth-Hitchcock Medical Center
Cigarette Smoking
Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
The recent Surgeon General's Report calls for effective and readily available treatment approaches to help adolescent smokers interested in quitting.
- Trial name
- NCT02218281
- Testing
- C2Q-Teen app, NCI's QuitSTART app, Written smoking cessation materials only
- Where
- United States
- Volunteers
- 146 people, healthy volunteers welcome
- Sponsor
- University of Massachusetts, Worcester
Nicotine Dependence
Approach Bias Retraining to Augment Smoking Cessation
Tobacco use is the most preventable cause of disease, disability, and death in the United States. Standard smoking cessation care (cognitive behavioral therapy and nicotine replacement therapy), is effective in approximately 20%…
- Trial name
- NCT03325777
- Testing
- Approach Bias Retraining
- Where
- United States
- Volunteers
- 96 people, healthy volunteers welcome
- Sponsor
- Jasper A. Smits
Smoking Cessation, Smoking (Tobacco) Addiction
PASCAL Feasibility Study
The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial…
- Trial name
- NCT07301151
- Testing
- chatbot, no chatbot
- Where
- United States
- Volunteers
- 120 people
- Sponsor
- University of Minnesota
Cancer, Smoking
Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke
The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Tobacco Use Treatment Service (TUTS) referral and engagement; and to explore clinician…
- Conditions
- Cancer, Smoking, Tobacco Use, Nicotine Dependence
- Trial name
- SPP1 (NCT04737031)
- Testing
- Clinician Nudge, Patient Nudge
- Where
- 3 sites in United States
- Volunteers
- 2,146 people
- Sponsor
- Abramson Cancer Center at Penn Medicine
Abuse Tobacco, Exposure
Perceptions of E-Cigarettes and Synthetic Cooling Agents, The ICE Study
This study evaluates how synthetic cooling additives like WS-3 and WS-23 impact e-cigarette perceptions, use behavior, and toxicant exposure.
- Trial name
- ICE (NCT06208202)
- Testing
- Behavioral Intervention, Biospecimen Collection, Survey Administration
- Where
- United States
- Volunteers
- 158 people, healthy volunteers welcome
- Sponsor
- Ohio State University Comprehensive Cancer Center
Smoking, Tobacco
CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers
The purpose of this Actual Use Study (AUS) is to investigate how United States (US) adult tobacco consumers 21 to 60 years of age, inclusive, who are regular smokers (≥5 cigarettes/day on at least 20 of the past 30 days) will use…
- Trial name
- NCT05960305
- Testing
- P1213416, P1213422, P1213716
- Where
- 12 sites in United States
- Volunteers
- 1,845 people, healthy volunteers welcome
- Sponsor
- RAI Services Company
Tobacco Use
Impact of Cigarette and E-cigarette Flavors on Adult Smoking Behavior
This study will investigate within-person changes in smoking behavior when current menthol smokers are switched to non-menthol cigarettes and either tobacco or menthol flavored e-cigarettes.
- Trial name
- NCT04009850
- Testing
- Cigarette Brand Switching, E-cigarette Flavor
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Yale University
Tobacco Use Cessation
VergeRx for Smokers Not Ready to Quit
This study uses a factorial optimization experiment to identify which treatment components help adults who smoke and are not ready to quit in the next 30 days (smokers not ready to quit, or SNRTQ) achieve smoking cessation.
- Trial name
- NCT07693660
- Testing
- VergeRx, SmokefreeTXT, NRT Lozenge (Combination)
- Where
- United States
- Volunteers
- 592 people, healthy volunteers welcome
- Sponsor
- University of Virginia
Tobacco, Tobacco Abstinence
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
The purpose of this study is to compare the advantages and disadvantages of two approaches for quitting smoking among people living with HIV (PWH).
- Conditions
- Tobacco, Tobacco Abstinence, Smoking Cessation, Smoking Cessation; Tobacco Dependence
- Trial name
- QMH (NCT06883097)
- Testing
- Learn to Quit-HIV (LTQ-H) App, QuitStart
- Where
- United States
- Volunteers
- 314 people
- Sponsor
- Wake Forest University Health Sciences
Smoking, Tobacco Use
IQOS (Non-Cigarette Tobacco Product) Pilot Study
A novel type of non-cigarette tobacco product was recently approved for sale in the US, the heated tobacco product (HTP) IQOS. IQOS may be less harmful than cigarettes, and there are some reports that it may produce more…
- Trial name
- NCT04357379
- Testing
- IQOS
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Medical University of South Carolina
Tobacco Use Disorder
Role of Metabolites in Nicotine Dependence (4) - 13
The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
- Trial name
- NCT00000296
- Testing
- Cotinine fumarate
- Where
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.